Christopher Patusky, Director at UNITED THERAPEUTICS Corp (UTHR), sold 2,300 shares at $200.16 ($460K) on 2021-11-08, disclosed to the SEC on 2021-11-08.
Seasonal sale ($460k) by Director — this insider has traded UTHR in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| UTHR | SELL | 2025-12-16 | $496K | — | Filing → |
| UTHR | SELL | 2025-03-20 | $3.0M | — | Filing → |
| UTHR | SELL | 2025-01-13 | $3.3M | — | Filing → |